The SLC2 (GLUT) family of glucose and polyol transporters are members of the major facilitator superfamily of membrane transporters and they are encoded by the SLC2 genes. GLUT family comprises fourteen members, which in humans are categorized into three classes based on sequence similarity. All GLUT proteins appear to have 12 transmembrane segments, a single site of N-linked glycosylation, a relatively large, central, cytoplasmic linker domain, and exhibit topologies with both their N and C termini positioned in the cytoplasm.
One or more GLUT proteins are expressed in almost every cell type in the human body. When expressed ectopically, all GLUTs appear to transport hexoses or polyols but the primary physiological substrates for several GLUTs remain uncertain. 11 of the 14 members of the GLUT family are able to transport glucose under experimental conditions. GLUTs 1-5 are the most thoroughly studied and all have a well-defined role as glucose and/or fructose transporters in a variety of tissues and cell types. The physiological interpretation for the protein redundancy of that transport glucose is likely to be a key property of this sugar as a circulating fuel in humans, thus requiring multiple glucose transporters with different kinetic and regulatory properties that are expressed in a cell-type specific manner.
Fig.1 Amino acid sequence and membrane topology of human GLUT1. (Mueckler, 2013)
The 14 members of GLUT family consists of 500 amino acid residues and can be divided into three classes based on the sequence similarity: Class 1 (GLUTs 1-4, 14); Class 2 (GLUTs 5, 7, 9, and 11); and Class 3 (GLUTs 6, 8, 10, 12, and HMIT).
Human SLC2 (GLUT) Family Members | ||||||
SLC2A2 | SLC2A3 | SLC2A4 | SLC2A5 | SLC2A6 | SLC2A7 | SLC2A8 |
SLC2A9 | SLC2A10 | SLC2A11 | SLC2A12 | SLC2A13 | SLC2A14 |
Aided by cutting-edge Magic™ membrane protein production platform, Creative Biolabs is proud to offer the preparation of these targets in required formats using various strategies, such as detergent micelles, proteoliposomes, nanodiscs, lipoparticles, polymers, stable cell line.
Meanwhile, our Magic™ membrane protein antibody discovery platform can help to discover antibodies against these targets, even fully humanized antibodies, by various approaches including hybridoma technology, phage display technology, etc. We also present DNA immunization service for anti-membrane protein antibody development. Please feel free to contact us for more information.
Reference
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.